A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2006
11/23/2006	WO2006122345A1 Method and composition for use in preparation of a patient for surgery
11/23/2006	WO2006100330A3 Polyene antibiotics, compositions containing said antibiotics, method and micro-organisms used to obtain same and applications thereof
11/23/2006	WO2006094828A3 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/23/2006	WO2006086188A3 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
11/23/2006	WO2006067518A3 Vaccines against neisseria meningitidis
11/23/2006	WO2006017369A3 Use of a farnesyl transferase inhibitor in the treatment of viral infections
11/23/2006	WO2005044292A3 Biomarkers of resistance to hiv-infections in humans and biological applications thereof
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264609 Use of heat shock proteins
11/23/2006	US20060264605 Polypeptides having anti-HIV activity and compositions comprising same
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060264517 Methods of reducing microbial resistance to drugs
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264468 Use of substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264397 Compositions and methods for targeting cancer cells
11/23/2006	US20060264391 Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequences
11/23/2006	US20060264390 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
11/23/2006	US20060264389 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/23/2006	US20060264385 like antiinfective (bactericide, fungicide, parasiticide, viricide), and antiproliferative, antiinflammatory, and prokinetic agents; 1,2,3-triazole-oxazolidine-phenyl- derivatives; effective against strains of cells or organisms that have developed drug resistance; administering orally
11/23/2006	US20060264370 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
11/23/2006	US20060263854 Immunodiagnostic assays using reducing agents
11/23/2006	US20060263846 S. penumoniae antigens
11/23/2006	US20060263820 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins
11/23/2006	US20060263455 Composition for preventing urinary system infections
11/23/2006	US20060263387 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
11/23/2006	US20060263386 Vaccines
11/23/2006	US20060263380 IL-12 as an adjuvant for Bordetella pertussis vaccines
11/23/2006	US20060263379 Bordetella pertussis antigen consisting lipopolysaccharide, pertusis toxin, filamentous hemagglutinin, pertactin or abosrbed to alum; interleukin-12 ; enhances cell-mediated immunity in a host
11/23/2006	US20060263376 Pharmaceutical composition comprising PIM-activated NKT cells, and use thereof in therapy
11/23/2006	US20060263333 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection
11/23/2006	US20060263305 Using azithromycin antibiotic
11/23/2006	DE10340277B4 Körperpflegemittel mit Silber-Agglomeraten Body care products with silver agglomerates
11/23/2006	DE102005022845A1 Thiobernsteinsäurederivate und deren Verwendung Thiobernsteinsäurederivate and their use
11/23/2006	CA2853335A1 Hivcon: an hiv immunogen and uses thereof
11/23/2006	CA2609043A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/23/2006	CA2608977A1 Antifungal agents
11/23/2006	CA2608468A1 Tri-, tetra-substituted-3-aminopyrrolidine derivative
11/23/2006	CA2608344A1 Method and composition for use in preparation of a patient for surgery
11/23/2006	CA2607472A1 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/22/2006	EP1724342A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient
11/22/2006	EP1724263A1 Basic amine compound and use thereof
11/22/2006	EP1723967A2 Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
11/22/2006	EP1723966A2 Oil in water emulsion vaccines
11/22/2006	EP1723964A1 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections
11/22/2006	EP1723253A2 Inhibitors of siderophore biosynthesis in fungi
11/22/2006	EP1723178A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/22/2006	EP1723160A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients
11/22/2006	EP1723152A1 Pyrrolobenzodiazepines
11/22/2006	EP1723150A1 Rifamycin imino derivatives effective against drug-resistant microbes
11/22/2006	EP1723136A1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
11/22/2006	EP1722822A1 New complexes
11/22/2006	EP1722782A2 Compounds, compositions and methods for inhibiting or treating hiv-1
11/22/2006	EP1722771A1 Compositions and methods for preventing or treating an inflammatory response
11/22/2006	EP1532129B1 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases
11/22/2006	EP1458683B1 Heteroaryl-substituted aminocyclohexane derivatives
11/22/2006	EP1454905B1 Novel substance fki-1083 and process for producing the same
11/22/2006	EP1438055A4 D-tagatose as an anti-biofilm agent
11/22/2006	EP1427717B1 Bioprecursors for percutaneous application
11/22/2006	EP1420778B1 Use of mek inhibitors for treating virus induced hemorrhagic shock or fever
11/22/2006	EP1370143B1 An antimicrobial composition
11/22/2006	EP1351933B1 Il-8 receptor antagonists
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1339725B1 Dna methyl transferase inhibitors
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1263781B1 Viral antigen and vaccine against isav (infectious salmon anaemia virus)
11/22/2006	EP1244651B1 Diamidine compounds as dna minor groove binders
11/22/2006	EP1220682B1 Stabilized liquid polypeptide-containing pharmaceutical compositions
11/22/2006	EP1073462B1 Combined vaccine against Hepatitis A and Hepatitis B
11/22/2006	EP1066247B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
11/22/2006	EP1054674B1 Oral liquid formulations of benzoxazinones hiv reverse transcriptase inhibitors
11/22/2006	EP1051395B1 N-hydroxyformamide derivatives
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	EP0780122B1 Depressant of functions developed by molecule
11/22/2006	CN1867588A Product comprising a c4bp core protein and a monomeric antigen, and its use
11/22/2006	CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1867356A 抗原递送系统 Antigen delivery system
11/22/2006	CN1867355A New vaccine containing mucosa immunity-inducing adjuvant
11/22/2006	CN1867352A Therapeutic uses of chemokine variants
11/22/2006	CN1867335A Novel use of quinolone antibiotics
11/22/2006	CN1865274A Macrolide analogue drug double sidechain illotycin A derivative, synthesis method and uses
11/22/2006	CN1864747A Method for preparing active carrier vaccine of avian Chlamydia psittaci
11/22/2006	CN1864736A A medicine for treating tinea pedis
11/22/2006	CN1864725A Method for extracting active ingredient of starofbethlehem and use thereof
11/22/2006	CN1864713A Spray for treating influenza and preparation method thereof
11/22/2006	CN1864703A A HIV killing formulation prepared by enzyme supplementation, fermentation and aging of yew
11/22/2006	CN1864702A Method for sieving and separating active substances from Chinese herbs, composition containing said active substances and application thereof
11/22/2006	CN1864691A Use of compound scalarafuran
11/22/2006	CN1864686A A pharmaceutical composition of microencapsulated cefuroxime axetil
11/22/2006	CN1864683A A preparation method of compound rifampicin preparation
11/22/2006	CN1864682A In-vitro in-vivo drug release characteristics of various drug pills in compound anti-tuberculosis preparation and application thereof
11/22/2006	CN1864681A Preparation method of composite rifampicin micro-tablet capsule
11/22/2006	CN1864676A Prescription of mecillinam composite preparation for injection and preparation method thereof
11/22/2006	CN1864674A Medical use of compound hyrtiosal

1 ... 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 ... 1798